Biotech & Life Science Fund A/S — Credit Rating and Financial Key Figures

CVR number: 42582557
Kongevejen 365, 2840 Holte

Income statement (kDKK)

2021
2022
2023
2024
Fiscal period length12121212
Net sales
External services-70.03- 229.89- 202.56- 174.89
Gross profit-70.03- 229.89- 202.56- 174.89
EBIT-70.03- 229.89- 202.56- 174.89
Other financial income84.96
Other financial expenses- 388.85- 821.70-1.44- 433.72
Pre-tax profit- 458.88-1 051.59- 119.04- 608.61
Net earnings- 458.88-1 051.59- 119.04- 608.61

Assets (kDKK)

2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Short term receivables total
Other current investments4 191.896 842.057 259.667 623.40
Cash and bank deposits6 165.025 231.973 450.44879.72
Cash and cash equivalents10 356.9212 074.0210 710.108 503.12
Balance sheet total (assets)10 356.9212 074.0210 710.108 503.12

Equity and liabilities (kDKK)

2021
2022
2023
2024
Share capital2 890.963 738.173 738.173 738.17
Retained earnings7 899.489 327.507 032.265 317.05
Profit of the financial year- 458.88-1 051.59- 119.04- 608.61
Shareholders equity total10 331.5612 014.0810 651.398 446.61
Non-current liabilities total
Other non-interest bearing current liabilities25.3659.9458.7156.50
Current liabilities total25.3659.9458.7156.50
Balance sheet total (liabilities)10 356.9212 074.0210 710.108 503.12
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.